Device Trial Radar · NCT01324271
inVENT-In-Office Study
Last checked: Nov 19, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
85
Actual
Start
Jan 2011
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Integra LifeSciences CorporationPublic (IART)
- Sponsor type
- Industry
- Collaborators
- Acclarent
- First posted
- Mar 29, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TTDS) for the placement of tympanostomy tubes (TT) under local anesthesia in an office/clinic setting.
Conditions
- Otitis Media
Interventions
Acclarent Tympanostomy Tube Delivery system (TTDS)Device
placement of tympanostomy tube under local anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With In-office Tube Placement Procedure SuccessTime frame: Day 0
- Percentage of Tubes Successfully Placed Using a TTDS DeviceTime frame: Day 0
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site not named
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.